Literature DB >> 10338521

Transcriptional activation of mRNA of intercellular adhesion molecule 1 and induction of its cell surface expression in normal human gingival fibroblasts by Mycoplasma salivarium and Mycoplasma fermentans.

L Dong1, K Shibata, Y Sawa, A Hasebe, Y Yamaoka, S Yoshida, T Watanabe.   

Abstract

Lipoproteins in the cell membranes of both Mycoplasma salivarium and Mycoplasma fermentans were demonstrated to trigger the transcription of intercellular adhesion molecule-1 mRNA in normal fibroblasts isolated from human gingival tissue and to induce its cell surface expression by a mechanism distinct from that of Escherichia coli lipopolysaccharide. The lipid moiety of the lipoproteins was suggested to play a key role in the expression of the activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10338521      PMCID: PMC96622          DOI: 10.1128/IAI.67.6.3061-3065.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  A simple technique for eliminating interference by detergents in the Lowry method of protein determination.

Authors:  J R Dulley; P A Grieve
Journal:  Anal Biochem       Date:  1975-03       Impact factor: 3.365

2.  Mycoplasma salivarium induces interleukin-6 and interleukin-8 in human gingival fibroblasts.

Authors:  K Shibata; A Hasebe; T Sasaki; T Watanabe
Journal:  FEMS Immunol Med Microbiol       Date:  1997-12

3.  Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).

Authors:  M L Dustin; R Rothlein; A K Bhan; C A Dinarello; T A Springer
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

4.  Possible role of Mycoplasma fermentans in pathogenesis of rheumatoid arthritis.

Authors:  M H Williams; J Brostoff; I M Roitt
Journal:  Lancet       Date:  1970-08-08       Impact factor: 79.321

5.  Mycoplasma salivarium in human gingival sulci.

Authors:  L D Engel; G E Kenny
Journal:  J Periodontal Res       Date:  1970       Impact factor: 4.419

6.  Identification and distribution of immunocompetent cells in inflamed gingiva of human chronic periodontitis.

Authors:  H Okada; T Kida; H Yamagami
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

7.  Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival, and tissue destruction.

Authors:  J Slots; R J Genco
Journal:  J Dent Res       Date:  1984-03       Impact factor: 6.116

8.  Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1).

Authors:  S D Marlin; T A Springer
Journal:  Cell       Date:  1987-12-04       Impact factor: 41.582

9.  Enumeration, isolation, and species identification of mycoplasmas in saliva sampled from the normal and pathological human oral cavity and antibody response to an oral mycoplasma (Mycoplasma salivarium).

Authors:  T Watanabe; M Matsuura; K Seto
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

10.  Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes.

Authors:  L Osborn; C Hession; R Tizard; C Vassallo; S Luhowskyj; G Chi-Rosso; R Lobb
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

View more
  8 in total

1.  Synergic effects of mycoplasmal lipopeptides and extracellular ATP on activation of macrophages.

Authors:  Takeshi Into; Mari Fujita; Tsugumi Okusawa; Akira Hasebe; Manabu Morita; Ken-Ichiro Shibata
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

2.  A 4.1-kilodalton polypeptide in the cultural supernatant of Mycoplasma fermentans is one of the substances responsible for induction of interleukin-6 production by human gingival fibroblasts.

Authors:  A Hasebe; K Shibata; T Watanabe
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

3.  The Toll-like receptor 2 (TLR2) ligand FSL-1 is internalized via the clathrin-dependent endocytic pathway triggered by CD14 and CD36 but not by TLR2.

Authors:  Haque M Shamsul; Akira Hasebe; Mitsuhiro Iyori; Makoto Ohtani; Kazuto Kiura; Diya Zhang; Yasunori Totsuka; Ken-ichiro Shibata
Journal:  Immunology       Date:  2010-01-27       Impact factor: 7.397

4.  Lipopolysaccharide preparation extracted from Porphyromonas gingivalis lipoprotein-deficient mutant shows a marked decrease in toll-like receptor 2-mediated signaling.

Authors:  Yasuyuki Asai; Masahito Hashimoto; Hansel M Fletcher; Kensuke Miyake; Shizuo Akira; Tomohiko Ogawa
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

5.  Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic, and respiratory plethysmographic profile.

Authors:  R D Hardy; H S Jafri; K Olsen; M Wordemann; J Hatfield; B B Rogers; P Patel; L Duffy; G Cassell; G H McCracken; O Ramilo
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

6.  Biological activities of Bacteroides forsythus lipoproteins and their possible pathological roles in periodontal disease.

Authors:  Akira Hasebe; Atsutoshi Yoshimura; Takeshi Into; Hideo Kataoka; Saori Tanaka; Shinichi Arakawa; Hiroaki Ishikura; Douglas T Golenbock; Tsutomu Sugaya; Nobuo Tsuchida; Masamitsu Kawanami; Yoshitaka Hara; Ken-Ichiro Shibata
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

7.  Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by toll-like receptors 2 and 6.

Authors:  Tsugumi Okusawa; Mari Fujita; Jun-Ichiro Nakamura; Takeshi Into; Motoaki Yasuda; Atsutoshi Yoshimura; Yoshitaka Hara; Akira Hasebe; Douglas T Golenbock; Manabu Morita; Yoshio Kuroki; Tomohiko Ogawa; Ken-Ichiro Shibata
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

8.  Mycoplasma fermentans inhibits the activity of cellular DNA topoisomerase I by activation of PARP1 and alters the efficacy of its anti-cancer inhibitor.

Authors:  Reuven Afriat; Shulamith Horowitz; Esther Priel
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.